Information  X 
Enter a valid email address

Augean Plc (AUG)

  Print      Mail a friend

Wednesday 09 January, 2019

Augean Plc

Trading update

RNS Number : 5575M
Augean Plc
09 January 2019
 

9 January 2019

 

Augean plc

("Augean" or "the Group")

Trading update, Board Change

& Notice of Results

 

 

Augean, one of the UK's leading specialist waste management businesses provides the following trading update for the year to 31 December 2018. Due to continuing strong Group trading performance through the second half of the financial year, the Group expects to be in line with previously upgraded market expectations for the full year. The Group has completed the year with higher net cash than market expectations, due to a stronger trading performance than expected in the later weeks of the year and favourable timing differences, at £8.2m (2017 net debt: £10.8m).

The Board also announces that Roderick Holdsworth, Non-Executive Director and Chairman of Audit Committee, has retired from the Board after almost three years of service. Rod has been instrumental in setting the standard for and ensuring the efficiency of our Audit Committee during his term. The Board have greatly valued Rod's advice and guidance and we would like to thank him for his input and support whilst serving the Board. As a result of this change, John Grant will take on the role of Chairman of the Audit Committee and Roger McDowell will take over as Chairman of the Remuneration Committee.

 

The Group's preliminary results for the year ended 31 December 2018 are expected to be announced on 26 February 2019.

 

 

 

 

 

-  Ends -

 

 

 

Enquiries:

 

Augean plc

Jim Meredith, Executive Chairman

Mark Fryer, Group Finance Director

 

01937 844 980

N+1 Singer

Shaun Dobson

Jen Boorer

Rachel Hayes 

 

020 7496 3000

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
TSTLLFEDLFITIIA

a d v e r t i s e m e n t